Financial News
Fate Therapeutics, Inc. - Common Stock (NQ: FATE )
1.260
+0.010
(+0.80%)
Streaming Delayed Price
Updated: 9:50 AM EST, Feb 13, 2025
Add to My Watchlist
Headline News about Fate Therapeutics, Inc. - Common Stock





Via Benzinga



Where Fate Therapeutics Stands With Analysts
April 11, 2024
Via Benzinga

Via Benzinga

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Fate Therapeutics
February 27, 2024
Via Benzinga


Recap: Fate Therapeutics Q4 Earnings
February 26, 2024
Via Benzinga


Analyst Ratings for Fate Therapeutics
November 09, 2023
Via Benzinga

Recap: Fate Therapeutics Q3 Earnings
November 08, 2023
Via Benzinga

Analyst Ratings for Fate Therapeutics
September 07, 2023
Via Benzinga

The Latest Analyst Ratings for Fate Therapeutics
August 16, 2023
Via Benzinga


A Preview Of Fate Therapeutics's Earnings
February 23, 2024
Via Benzinga

Where Fate Therapeutics Stands With Analysts
May 05, 2023
Via Benzinga

Fate Therapeutics: Q1 Earnings Insights
May 03, 2023
Via Benzinga

Fate Therapeutics Earnings Preview
May 02, 2023
Via Benzinga

Pinstripes, SoFi Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 03, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities

12 Health Care Stocks Moving In Tuesday's After-Market Session
December 12, 2023
Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.